{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:08:49Z","timestamp":1761512929728},"reference-count":35,"publisher":"Frontiers Media SA","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1669,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1111\/j.1432-2277.2011.01228.x","type":"journal-article","created":{"date-parts":[[2011,2,5]],"date-time":"2011-02-05T09:13:57Z","timestamp":1296897237000},"page":"461-468","source":"Crossref","is-referenced-by-count":22,"title":["Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C"],"prefix":"10.3389","volume":"24","author":[{"given":"Tommaso Maria","family":"Manzia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Angelico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Toti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Irene","family":"Bellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Sforza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giampiero","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Orlando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Tariciotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Angelico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Tisone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2011,2,5]]},"reference":[{"key":"10.1111\/j.1432-2277.2011.01228.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0168-8278(01)00179-9","article-title":"Hepatitis C and liver transplantation","volume":"35","author":"Berenguer","year":"2001","journal-title":"J Hepatol"},{"key":"10.1111\/j.1432-2277.2011.01228.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJM199603283341302","article-title":"Long-term outcome of hepatitis C viral infection after liver transplantation","volume":"334","author":"Gane","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1432-2277.2011.01228.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1002\/lt.21646","article-title":"The natural history of recurrent Hepatitis C and what influences this","volume":"14","author":"Gane","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2011.01228.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0168-8278(00)80231-7","article-title":"HCV-related fibrosis progression following liver transplantation: increase in recent years","volume":"32","author":"Berenguer","year":"2000","journal-title":"J Hepatol"},{"key":"10.1111\/j.1432-2277.2011.01228.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00007890-200201150-00010","article-title":"Impact of recurrence of HCV infection after liver transplantation on the long-term variability of the graft","volume":"73","author":"S\u00e1nchez-Fueyo","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2011.01228.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jhep.2005.01.011","article-title":"What determines the natural history of recurrent hepatitis C after liver transplantation?","volume":"45","author":"Berenguer","year":"2005","journal-title":"J Hepatol"},{"issue":"1 Suppl.","key":"10.1111\/j.1432-2277.2011.01228.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1097\/01.tp.0000187133.53916.8f","article-title":"Indications of mycophenolate mofetil in liver transplantation","volume":"80","author":"Klupp","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2011.01228.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(96)10310-X","article-title":"Mycophenolate mofetil","volume":"348","author":"Lipsky","year":"1996","journal-title":"Lancet"},{"key":"10.1111\/j.1432-2277.2011.01228.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/01.TP.0000071522.74885.48","article-title":"Mycophenolate mofetil for immunosuppression after liver transplantation: a follow up study of 191 patients","volume":"76","author":"Pfitzmann","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2011.01228.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00007890-199907150-00029","article-title":"Mycophenolate mofetil monotherapy in stable liver transplant patients with cyclosporine-induced renal impairment: a preliminary report","volume":"68","author":"Papatheodoridis","year":"1999","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2011.01228.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1432-2277.2004.tb00481.x","article-title":"Long-term efficacy and safety of mycophenolate mofetil in liver transplant recipients with calcineurin-inhibitors-induced renal dysfunction","volume":"17","author":"Koch","year":"2004","journal-title":"Transpl Int"},{"key":"10.1111\/j.1432-2277.2011.01228.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/00007890-199903150-00011","article-title":"Four-year-follow-up of mycophenolate mofetil for graft rescue in liver allograft recipients","volume":"67","author":"Hebert","year":"1999","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2011.01228.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1097\/00007890-200005150-00025","article-title":"Improvement of acute and chronic renal dysfunction in liver transplant patients after substitution of calcineurin inhibitors by mycophenolate mofetil","volume":"69","author":"Barkmann","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2011.01228.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.TP.0000165118.00988.D7","article-title":"Mycophenolate mofetil for renal dysfunction in liver transplant recipients on cyclosporine or tacrolimus: randomized, prospective, multicenter pilot study results","volume":"80","author":"Reich","year":"2005","journal-title":"Transplant"},{"key":"10.1111\/j.1432-2277.2011.01228.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/lt.20926","article-title":"Switch to 1.5 grams MMF monotherapy for CNI-related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension","volume":"13","author":"Orlando","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2011.01228.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0140-6736(00)04055-1","article-title":"Replacement of calcineurin inhibitors with mycophenolate mofetil in liver transplant patients with renal dysfunction: a randomized controlled study","volume":"357","author":"Schlitt","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.1432-2277.2011.01228.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/01.TP.0000041702.31262.CD","article-title":"Long-term mycophenolate mofetil monotherapy in combination with calcineurin inhibitors for chronic renal dysfunction after liver transplantation","volume":"75","author":"Raimondo","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2011.01228.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/lt.20210","article-title":"Mycophenolate mofetil monotherapy in liver transplant recipients: a single center experience","volume":"10","author":"Fairbanks","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2011.01228.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/lt.500050513","article-title":"Conversion of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetil","volume":"5","author":"Herrero","year":"1999","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2011.01228.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1111\/j.1600-6143.2004.00556.x","article-title":"Mycophenolate mofetil can be used as monotherapy late after liver transplantation","volume":"4","author":"Moreno Planas","year":"2004","journal-title":"Am J Transpl"},{"key":"10.1111\/j.1432-2277.2011.01228.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(00)04065-4","article-title":"Mycophenolate mofetil monotherapy in liver transplantation","volume":"357","author":"Stewart","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.1432-2277.2011.01228.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1016\/j.transproceed.2005.06.005","article-title":"Mycophenolate mofetil monotherapy in liver transplantation","volume":"37","author":"Pierini","year":"2005","journal-title":"Transpl Proc"},{"key":"10.1111\/j.1432-2277.2011.01228.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1124\/jpet.106.117051","article-title":"In vitro evidence for a direct antifibrotic role of the immunosuppressive drug mycophenolate mofetil","volume":"321","author":"Roos","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl.","key":"10.1111\/j.1432-2277.2011.01228.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1111\/j.1399-0012.2006.00597.x","article-title":"Antifibrotic actions of mycophenolic acid","volume":"17","author":"Morath","year":"2006","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1432-2277.2011.01228.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1600-6143.2004.00706.x","article-title":"MMF and calcineurin taper in recurrent hepatitis C after liver transplantation: impact on histological course","volume":"5","author":"Bahra","year":"2005","journal-title":"Am J Transpl"},{"key":"10.1111\/j.1432-2277.2011.01228.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol"},{"key":"10.1111\/j.1432-2277.2011.01228.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/hep.510250328","article-title":"Banff schema for grading liver allograft rejection: an international consensus document","volume":"25","year":"1997","journal-title":"Hepatology"},{"key":"10.1111\/j.1432-2277.2011.01228.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/lt.21699","article-title":"Impact of the donor risk index on the outcome of hepatitis C Virus-positive liver transplantation recipients","volume":"15","author":"Maluf","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2011.01228.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/lt.20865","article-title":"Treating hepatitis C infection in liver transplant recipients","volume":"12","author":"Terrault","year":"2006","journal-title":"Liver Traspl"},{"key":"10.1111\/j.1432-2277.2011.01228.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/jlts.2003.50268","article-title":"Report of the first international liver transplantation society expert panel consensus conference on liver transplantation and hepatitis C","volume":"9","author":"Wiesner","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2011.01228.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/lt.20304","article-title":"Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: a decision analysis","volume":"10","author":"Amin","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2011.01228.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1399-3062.2007.00228.x","article-title":"Conversion to mycophenolate mofetil for modulating recurrent hepatitis C in liver transplant recipients","volume":"9","author":"Kornberg","year":"2007","journal-title":"Transplant Infections Disease."},{"key":"10.1111\/j.1432-2277.2011.01228.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1053\/j.gastro.2006.08.027","article-title":"Mycophenolic acid inhibits hepatitis c virus replication and acts in synergy with cyclosporin A and interferon-\u03b1","volume":"131","author":"Henry","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1432-2277.2011.01228.x-BIB34|cit34","article-title":"Immunosuppressive strategies in transplantation","volume":"1","author":"Denton","year":"1999","journal-title":"Lancet"},{"key":"10.1111\/j.1432-2277.2011.01228.x-BIB35|cit35","first-page":"40","article-title":"Safety of mycophenolate mofetil monotherapy in patients after liver transplantation","volume":"14","author":"Kamphues","year":"2009","journal-title":"Ann Transplant"}],"container-title":["Transplant International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1432-2277.2011.01228.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1432-2277.2011.01228.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T18:34:34Z","timestamp":1641062074000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1432-2277.2011.01228.x"}},"subtitle":["MMF improves the fibrosis course in HCV LT-recipients"],"short-title":[],"issued":{"date-parts":[[2011,2,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1432-2277.2011.01228.x","relation":{},"ISSN":["0934-0874"],"issn-type":[{"value":"0934-0874","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2,5]]}}}